Compile Data Set for Download or QSAR
Report error Found 33 Enz. Inhib. hit(s) with all data for entry = 12858
TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734323(US20250129032, Example 31)
Affinity DataIC50: 1.06nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734315((S)-5-(1-fluoro-3-hydroxy-7-((methylamino)methyl)-...)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734322(US20250129032, Example 30)
Affinity DataIC50: 2.28nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734302(US20250129032, Example 10)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734293((R)-5-(7-(2-aminoethyl)-1-fluoro-3-hydroxy-6,7,8,9...)
Affinity DataIC50: 5.07nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734298(US20250129032, Example 6)
Affinity DataIC50: 5.67nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734308(US20250129032, Example 16)
Affinity DataIC50: 10.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734311(US20250129032, Example 19)
Affinity DataIC50: 12.4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734312(US20250129032, Example 20)
Affinity DataIC50: 12.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734306(US20250129032, Example 14)
Affinity DataIC50: 13.6nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734296(US20250129032, Example 4)
Affinity DataIC50: 14.9nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734295(US20250129032, Example 3)
Affinity DataIC50: 16.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734297(US20250129032, Example 5)
Affinity DataIC50: 17.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734318(US20250129032, Example 26)
Affinity DataIC50: 19.8nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734304(US20250129032, Example 12)
Affinity DataIC50: 19.8nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734325(US20250129032, Example 33)
Affinity DataIC50: 21.1nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734301(US20250129032, Example 9)
Affinity DataIC50: 21.6nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734314(US20250129032, Example 22)
Affinity DataIC50: 24.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734317(5-(1-fluoro-3-hydroxy-8-(isopentylamino)-6,7,8,9-t...)
Affinity DataIC50: 25.9nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734320(US20250129032, Example 28)
Affinity DataIC50: 39.9nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734324(US20250129032, Example 32)
Affinity DataIC50: 46.9nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734300(US20250129032, Example 8)
Affinity DataIC50: 47.3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734316(US20250129032, Example 24)
Affinity DataIC50: 75nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734307(US20250129032, Example 15)
Affinity DataIC50: 79.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734305(US20250129032, Example 13)
Affinity DataIC50: 85.3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734309(US20250129032, Example 17)
Affinity DataIC50: 93nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734321(US20250129032, Example 29)
Affinity DataIC50: 109nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734303(US20250129032, Example 11)
Affinity DataIC50: 149nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734294(US20250129032, Example 2)
Affinity DataIC50: 176nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734319(US20250129032, Example 27)
Affinity DataIC50: 215nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734313(US20250129032, Example 21)
Affinity DataIC50: 374nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734299(US20250129032, Example 7)
Affinity DataIC50: 444nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734310(US20250129032, Example 18)
Affinity DataIC50: 879nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
Go to US Patent